Cover Image
Market Research Report
Product code 
1072552

Europe Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027

Published: | KBV Research | 101 Pages | Delivery time: 1-2 business days

Price

Back to Top
Europe Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027
Published: March 31, 2022
KBV Research
Content info: 101 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Europe Transcriptomics Market would witness market growth of 7.1% CAGR during the forecast period (2021-2027).

The transcriptomics market is predicted to grow due to developments in the domain of transcriptomics, such as the widespread use of RNA-sequencing and an increase in applications of transcriptomics, such as drug discovery. Moreover, an increase in financing and grants from various business and government entities would help the market in the long run. In addition, prominent market players are concentrating their efforts on increasing their transcriptomics footprints by strategic alliances and collaborations with other players. Furthermore, the organizations are developing ways to extend their global consumer base. Dovetail Genomics, for example, announced the global availability of its Dovetail HiChIP and Micro-C Kits in February 2020.

In the recent years, due to the genome projects, an increase in R&D expenditure is being undertaken all over the world. The GENE Consortium, a top whole genome sequencing program in Europe, was founded in the United Kingdom with the goal of sequencing up to 100,000 genomes from cancer patients, rare illness patients, and their relatives from 11 genomic medicine institutes. In addition, the Italian Institute of Technology and the European Molecular Biology Laboratory inked a partnership agreement in April 2021 to increase their research collaboration. This agreement is expected to boost their database and allow them to exchange study resources. The RNA program, which focuses on non-coding RNAs, was recently launched at the Italian Institute of Technology.

The high demand to study on Gene Expression Level through Transcriptomics would help the regional market to offer enough opportunities for the industry players. Low-abundance targets and tiny changes in gene expression, which are crucial for investigating the biological response to stimulation or environmental changes, are difficult to detect with gene microarray methods.

The Germany market dominated the Europe Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $601.4 million by 2027. The UK market is poised to grow at a CAGR of 6.3% during (2021 - 2027). Additionally, The France market would experience a CAGR of 7.9% during (2021 - 2027).

Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.

Scope of the Study

Market Segments covered in the Report:

By Technology

  • q PCR
  • Microarrays
  • Sequencing Technology

By Application

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

By Component

  • Consumables
  • Instruments
  • Software
  • Services

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Fluidigm Corporation
  • Promega Corporation
  • General Electric (GE) Co.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Transcriptomics Market, by Technology
    • 1.4.2 Europe Transcriptomics Market, by Application
    • 1.4.3 Europe Transcriptomics Market, by Component
    • 1.4.4 Europe Transcriptomics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players

Chapter 4. Europe Transcriptomics Market by Technology

  • 4.1 Europe q PCR Market by Country
  • 4.2 Europe Microarrays Market by Country
  • 4.3 Europe Sequencing Technology Market by Country

Chapter 5. Europe Transcriptomics Market by Application

  • 5.1 Europe Drug Discovery Market by Country
  • 5.2 Europe Diagnostics & Disease Profiling Market by Country
  • 5.3 Europe Others Market by Country

Chapter 6. Europe Transcriptomics Market by Component

  • 6.1 Europe Consumables Market by Country
  • 6.2 Europe Instruments Market by Country
  • 6.3 Europe Software Market by Country
  • 6.4 Europe Services Market by Country

Chapter 7. Europe Transcriptomics Market by Country

  • 7.1 Germany Transcriptomics Market
    • 7.1.1 Germany Transcriptomics Market by Technology
    • 7.1.2 Germany Transcriptomics Market by Application
    • 7.1.3 Germany Transcriptomics Market by Component
  • 7.2 UK Transcriptomics Market
    • 7.2.1 UK Transcriptomics Market by Technology
    • 7.2.2 UK Transcriptomics Market by Application
    • 7.2.3 UK Transcriptomics Market by Component
  • 7.3 France Transcriptomics Market
    • 7.3.1 France Transcriptomics Market by Technology
    • 7.3.2 France Transcriptomics Market by Application
    • 7.3.3 France Transcriptomics Market by Component
  • 7.4 Russia Transcriptomics Market
    • 7.4.1 Russia Transcriptomics Market by Technology
    • 7.4.2 Russia Transcriptomics Market by Application
    • 7.4.3 Russia Transcriptomics Market by Component
  • 7.5 Spain Transcriptomics Market
    • 7.5.1 Spain Transcriptomics Market by Technology
    • 7.5.2 Spain Transcriptomics Market by Application
    • 7.5.3 Spain Transcriptomics Market by Component
  • 7.6 Italy Transcriptomics Market
    • 7.6.1 Italy Transcriptomics Market by Technology
    • 7.6.2 Italy Transcriptomics Market by Application
    • 7.6.3 Italy Transcriptomics Market by Component
  • 7.7 Rest of Europe Transcriptomics Market
    • 7.7.1 Rest of Europe Transcriptomics Market by Technology
    • 7.7.2 Rest of Europe Transcriptomics Market by Application
    • 7.7.3 Rest of Europe Transcriptomics Market by Component

Chapter 8. Company Profiles

  • 8.1 Fluidigm Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Product Launches and Product Expansions:
  • 8.2 Promega Corporation
    • 8.2.1 Company Overview
  • 8.3 General Electric (GE) Co. (GE Healthcare)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Merck & Co., Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
  • 8.5 Thermo Fisher Scientific, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Acquisition and Mergers:
    • 8.5.6 SWOT Analysis
  • 8.6 Illumina, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
  • 8.7 Bio-Rad laboratories, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Product Launches and Product Expansions:
      • 8.7.5.3 Acquisition and Mergers:
  • 8.8 Agilent Technologies, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Acquisition and Mergers:
  • 8.9 F. Hoffmann-La Roche Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.10. Qiagen N.V.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
      • 8.10.5.2 Product Launches and Product Expansions:
      • 8.10.5.3 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 Europe Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 2 Europe Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Transcriptomics Market
  • TABLE 4 Product Launches And Product Expansions - Transcriptomics Market
  • TABLE 5 Acquisition and Mergers- Transcriptomics Market
  • TABLE 6 Europe Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 7 Europe Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 8 Europe q PCR Market by Country, 2017 - 2020, USD Million
  • TABLE 9 Europe q PCR Market by Country, 2021 - 2027, USD Million
  • TABLE 10 Europe Microarrays Market by Country, 2017 - 2020, USD Million
  • TABLE 11 Europe Microarrays Market by Country, 2021 - 2027, USD Million
  • TABLE 12 Europe Sequencing Technology Market by Country, 2017 - 2020, USD Million
  • TABLE 13 Europe Sequencing Technology Market by Country, 2021 - 2027, USD Million
  • TABLE 14 Europe Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 15 Europe Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 16 Europe Drug Discovery Market by Country, 2017 - 2020, USD Million
  • TABLE 17 Europe Drug Discovery Market by Country, 2021 - 2027, USD Million
  • TABLE 18 Europe Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
  • TABLE 19 Europe Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
  • TABLE 20 Europe Others Market by Country, 2017 - 2020, USD Million
  • TABLE 21 Europe Others Market by Country, 2021 - 2027, USD Million
  • TABLE 22 Europe Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 23 Europe Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 24 Europe CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
  • TABLE 25 Europe Consumables Market by Country, 2021 - 2027, USD Million
  • TABLE 26 Europe INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
  • TABLE 27 Europe INSTRUMENTS MARKET by Country, 2021 - 2027, USD Million
  • TABLE 28 Europe SOFTWARE MARKET by Country, 2017 - 2020, USD Million
  • TABLE 29 Europe SOFTWARE MARKET by Country, 2021 - 2027, USD Million
  • TABLE 30 Europe Services Market by Country, 2017 - 2020, USD Million
  • TABLE 31 Europe Services Market by Country, 2021 - 2027, USD Million
  • TABLE 32 Europe Transcriptomics Market by Country, 2017 - 2020, USD Million
  • TABLE 33 Europe Transcriptomics Market by Country, 2021 - 2027, USD Million
  • TABLE 34 Germany Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 35 Germany Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 36 Germany Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 37 Germany Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 38 Germany Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 39 Germany Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 40 Germany Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 41 Germany Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 42 UK Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 43 UK Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 44 UK Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 45 UK Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 46 UK Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 47 UK Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 48 UK Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 49 UK Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 50 France Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 51 France Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 52 France Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 53 France Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 54 France Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 55 France Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 56 France Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 57 France Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 58 Russia Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 59 Russia Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 60 Russia Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 61 Russia Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 62 Russia Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 63 Russia Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 64 Russia Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 65 Russia Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 66 Spain Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 67 Spain Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 68 Spain Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 69 Spain Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 70 Spain Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 71 Spain Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 72 Spain Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 73 Spain Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 74 Italy Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 75 Italy Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 76 Italy Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 77 Italy Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 78 Italy Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 79 Italy Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 80 Italy Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 81 Italy Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 82 Rest of Europe Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 83 Rest of Europe Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 84 Rest of Europe Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 85 Rest of Europe Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 86 Rest of Europe Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 87 Rest of Europe Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 88 Rest of Europe Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 89 Rest of Europe Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 90 Key Information - Fluidigm Corporation
  • TABLE 91 key Information - Promega Corporation
  • TABLE 92 Key Information - General Electric (GE) Co.
  • TABLE 93 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 94 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 95 key information - Illumina, Inc.
  • TABLE 96 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 97 key Information - Agilent Technologies, Inc.
  • TABLE 98 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 99 Key Information - Qiagen N.V.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
  • FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
  • FIG 8 Recent strategies and developments: Qiagen N.V.